We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ultra-Minilaparotomy Possibly Effective for Uterine Fibroids

By HospiMedica International staff writers
Posted on 28 Jan 2010
Ultra-minilaparotomy (UMLT) myomectomy and laparoscopically assisted UMLT (LA-UMLT) myomectomy may offer some advantages in the management of selected patients with uterine fibroids compared with traditional laparotomy (LA), according to a new study.

Researchers at the National Yang-Ming University School of Medicine (Taipei, Taiwan; nymu-e.web.ym.edu.tw) conducted a cohort study that included 79 (35.3%) women in the LT group, 71 (31.7%) in the UMLT group, and 74 (33%) in the LA- UMLT group. More...
All groups included women suffering from fewer than five uterine fibroids smaller than 8 cm in size. Outcomes were measured by comparing surgical parameters, immediate postoperative recovery, and therapeutic consequences.

The results showed that during a median follow-up of 52 months, similar recurrence rates were observed in the three groups. However, the two modified approaches had advantages not only in the surgical parameters, but also in postoperative recovery, compared to LT. The study was published early online in the December 25, 2009, issue of the American Journal of Obstetrics & Gynecology.

"The modified approaches, UMLT and LA-UMLT, are both safe, minimal-access options in place of LT in the successful management of uterine fibroids, since they have the advantage of rapid postoperative recovery,” concluded lead author Kuo-Chang Wen, M.D., and colleagues. "UMLT might be more feasible in the management of uterine fibroids, since it is an easy-to-perform technique. For uterine fibroids located laterally to posteriorly, LA-UMLT may be an alternative.”

Uterine fibroids are benign tumors that originate from the smooth muscle layer (myometrium) and the accompanying connective tissue of the uterus. Fibroids are the most common benign tumors in females and typically found during the middle and later reproductive years. While most fibroids are asymptomatic, they can grow and cause heavy and painful menstruation, painful sexual intercourse, and urinary frequency and urgency. Fibroids are often multiple and if the uterus contains too many leiomyomatas to count, it is referred to as uterine leiomyomatosis. Uterine fibroids are the major indication for hysterectomy.

Related Links:

National Yang-Ming University School of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.